Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04392037 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone

Study acronym: ICON
StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 2024 to Dec 2027v11
  2. Re-verified, no change to tracked fieldsv10
  3. Primary and study completion dates: Nov 2023 to Dec 2024v9
  4. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 9 of 9 sites
    v8
  5. Re-verified, no change to tracked fieldsv7
Show 5 earlier versionsHide 5 earlier versions
  1. Site details revised at 4 of 9 sitesv6
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 11 to 9
    • Start date changed from estimate of Nov 2020 to Feb 17, 2021
    v5
  3. Study sites: 10 to 11
    • Eligibility criteria revised
    v4
  4. Start date: Jul 2020 to Nov 2020
    • Primary and study completion dates: Jul 2023 to Nov 2023
    v3
  5. Secondary endpoints: details revised at 1 of 7 entries
    • Study description shortened, about 1 word
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Evaluation of the effect iberdomide combined with low-dose cyclophosphamide and dexamethasone in patients with relapsed/refractory multiple myeloma.
Trial Details
NCT Number NCT04392037
Lead Sponsor Amsterdam UMC, location VUmc
Collaborators: Celgene
Conditions
(from sponsor)		 Multiple Myeloma
Related terms Multiple Myeloma
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov